Dale Broadrick - 01 Jun 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: 10%+ Owner
Signature: /s/ Dale Broadrick
Issuer symbol: BRTX
Transactions as of: 01 Jun 2022
Net transactions value: +$41,122
Form type: 4
Filing time: 03 Jun 2022, 16:03:43 UTC
Previous filing: 01 Jun 2022
Next filing: 06 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRTX	Common Stock	Purchase	$41,122	+9,213	+3.4%	$4.46	277,473	01 Jun 2022	Direct	F1
holding	BRTX	Common Stock						316,972	01 Jun 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BRTX	Warrant to acquire Common Stock						125	01 Jun 2022	Common Stock	125	$120.00	Direct
holding	BRTX	Warrant to acquire Common Stock						125	01 Jun 2022	Common Stock	125	$120.00	Direct
holding	BRTX	Warrant to acquire Common Stock						138	01 Jun 2022	Common Stock	138	$120.00	Direct
holding	BRTX	Warrant to acquire Common Stock						138	01 Jun 2022	Common Stock	138	$120.00	Direct
holding	BRTX	Warrant to acquire Common Stock						833	01 Jun 2022	Common Stock	833	$120.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $4.0659 to $4.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F2	Owned by Fleetco, Inc. of which reporting person is a 93% shareholder.